Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$372,916
-$23,735 QoQ
Shares Held
6,472
-1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,719
of 2,506 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026McLean Asset Management Corp holds $5,605,267 across 9 Drug Manufacturers - General names. BMY ranks #7 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,420 | $1,703,190 | |
| 2 | JNJ |
Johnson & Johnson
|
3,218 | $817,275 | |
| 3 | ABBV |
AbbVie Inc.
|
3,136 | $789,143 | |
| 4 | AZN |
Astrazeneca PLC
|
3,240 | $614,368 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,870 | $497,295 | |
| 6 | AMGN |
Amgen Inc
|
1,064 | $385,295 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
6,472 | $372,916 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,768 | $223,369 |
All Filings in BMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $372,916 | 6,472 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $396,651 | 6,540 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $348,722 | 6,465 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $282,912 | 6,273 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $293,061 | 6,331 | Shares | Sole | 2025-07-03 | |
| 2025-03-31 | $397,105 | 6,511 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $376,802 | 6,662 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $333,723 | 6,450 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $263,673 | 6,349 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $391,757 | 7,224 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $381,181 | 7,429 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $434,835 | 7,492 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $483,014 | 7,553 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $519,339 | 7,493 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $555,166 | 7,716 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $546,255 | 7,684 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $595,980 | 7,740 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $567,735 | 7,774 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $477,164 | 7,653 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $432,473 | 7,309 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $419,295 | 6,275 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $392,163 | 6,212 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $397,178 | 6,403 | Shares | Sole | 2021-01-27 | |
| No filing history on record for this holder in this stock. | ||||||